Edition:
United States

People: Astellas Pharma Inc (4503.T)

4503.T on Tokyo Stock Exchange

1,360JPY
21 Jul 2017
Change (% chg)

-- (--)
Prev Close
¥1,360
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
7,927,527
52-wk High
¥1,779
52-wk Low
¥1,332

Hatanaka, Yoshihiko 

Mr. Yoshihiko Hatanaka has been serving as President, Chief Executive Officer and Representative Director in Astellas Pharma Inc. since April 1, 2017. His previous titles include Executive Officer and Senior Executive Officer in the Company. He previously served as President and Chief Executive Officer in two US-based subsidiaries. He used to work for Fujisawa Pharmaceutical Co., Ltd. He obtained his bachelor's degree in Economics from Hitotsubashi University in May 1980.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --